Amgen Seeks to Toss $50 Million Blincyto Loss on Lindis Patents
Amgen Inc. urged a federal judge to overturn a jury’s $50.3 million verdict for its leukemia drug Blincyto’s infringement of ...
heraldsun.com.au15d
This immunotherapy drug helped me beat cancer - instead of $229k it now costs $31
Associate Professor Shaun Fleming said the listing of Blincyto meant patients could avoid the potentially fatal side effects of chemotherapy. “Typically, patients with ALL are being treated with ...